AI-generated summary
This review discusses blue-light phototherapy used for dermatologic conditions and its potential eye hazards. The authors report that excessive ocular blue-light exposure may contribute to age-related macular degeneration and other vision problems. They recommend that patients and operators use carefully selected protective eyewear during each therapy session.
- Limits stated in the abstract
- The abstract does not report the number of studies reviewed, the study designs, or the strength of the evidence linking blue light to retinal disease.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Age-related macular degeneration, Phototherapy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.